Adam Esbenshade MD

Pediatric Hematology & Oncology•Nashville, TN

Associate Professor, Pediatrics, Vanderbilt University School of Medicine

Join to View Full Profile

397 Prb 2220 Pierce AveNashville, TN 37232
Phone+1 615-936-1762
Fax+1 615-936-1767

Education & Training

Vanderbilt University Medical CenterFellowship, Pediatric Hematology/Oncology, 2007 - 2010
University of TennesseeResidency, Pediatrics, 2004 - 2007
University of Tennessee Health Science Center College of MedicineClass of 2004

Certifications & Licensure

TN State Medical License 2008 - 2027
AL State Medical License 2020 - 2020
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Metabolic Syndrome in Young Patients With Acute Lymphoblastic Leukemia in Remission Start of enrollment: 2008 Nov 01
Completed
Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors Start of enrollment: 2004 Feb 16
Completed
Methemoglobinemia in Patients With Childhood Hematologic Cancer or Aplastic Anemia Treated With Dapsone Start of enrollment: 2009 Jun 01
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Start of enrollment: 2010 May 07
ACTIVE_NOT_RECRUITING
PHASE3
Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Start of enrollment: 2010 Nov 22
Completed
Phase 2
Ceftriaxone in Non-neutropenic Fever Start of enrollment: 2010 Aug 01
Completed
Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor Start of enrollment: 2011 Aug 01
Completed
Phase 2
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant Start of enrollment: 2013 Mar 21
COMPLETED
PHASE3
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors Start of enrollment: 2012 Jun 27
COMPLETED
PHASE2
HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors
ACTIVE_NOT_RECRUITING
PHASE4
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Prevention and Management of Infectious Complications in Pediatric Patients With Cancer: A Survey Assessment of Current Practices Across Children's Oncology Group Inst...
Leonora R Slatnick, David Hoogstra, Brian T Fisher, Joshua Wolf, Etan Orgel
Pediatric Blood & Cancer. 2025-03-01
Should Our Patients Go to Disney World? Weighing the Risk of Infection Versus the Benefits of Social Interactions in Our Pediatric Oncology Patients.
Sara E Manning, Adam J Esbenshade
JCO Oncology Practice. 2025-02-01
Impact of the COVID-19 Pandemic Onset on the Early Careers of Pediatric Oncology Health Professionals and Researchers: A Report From the Children's Oncology Group Youn...
Gemma Bryan, Louise Guolla, Gabriela Inés Villanueva, Sarah Cohen-Gogo, Alejandra Casanovas
Pediatric Blood & Cancer. 2025-01-01

Press Mentions

Four Elected to American Pediatric SocietyNovember 14th, 2024
Hyundai Hope on Wheels Award Boosts Pediatric Cancer ResearchAugust 24th, 2017